Apellis Pharmaceuticals, Inc.
2020 Q2 - 2026 Q1 (11 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2026 Q1 | 5/15/2026 | 2,481 | 0.0% | 61,681 | 3/31/2026 |
| 2024 Q1 | 5/15/2024 | 1,179 | 0.0% | 20,057 | 3/31/2024 |
| 2023 Q4 | 2/14/2024 | 1,147 | 0.0% | 19,154 | 12/31/2023 |
| 2023 Q3 | 11/17/2023 | 4,166 | 0.0% | 109,508 | 9/30/2023 |
| 2021 Q4 | 2/14/2022 | 14,685 | 0.1% | 310,594 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 16,930 | 0.1% | 513,641 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 7,775 | 0.1% | 123,025 | 6/30/2021 |
| 2021 Q1 | 5/17/2021 | 11,211 | 0.1% | 261,268 | 3/31/2021 |
| 2020 Q4 | 2/16/2021 | 4,598 | 0.0% | 80,381 | 12/31/2020 |
| 2020 Q3 | 11/16/2020 | 3,628 | 0.0% | 120,243 | 9/30/2020 |
| 2020 Q2 | 8/17/2020 | 2,597 | 0.0% | 79,512 | 6/30/2020 |